| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |